{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/60b1306d44938a0013db19cf/61813ff3f2a3a0001420bc39?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Optimizing patient-first clinical trials with advanced site intelligence  ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/60b1306d44938a0013db19cf/1623315228296-0f6d70af5a62181f19e3343e22b64ea2.jpeg?height=200","description":"<p>In this episode of Conversations in Healthcare, Mike Ward&nbsp;speaks with Oriol Serra,&nbsp;former&nbsp;Head of Site Intelligence&nbsp;and&nbsp;Selection at Pfizer&nbsp;and&nbsp;Simon Andrews, Vice President&nbsp;of&nbsp;RWD&nbsp;Engagements&nbsp;and Innovations at Clarivate about optimizing&nbsp;patient-first&nbsp;clinical trial design&nbsp;and ensuring&nbsp;trial groups align to&nbsp;real-life populations and needs.&nbsp;&nbsp;</p><p>&nbsp;</p><p>The group discusses&nbsp;the ins and outs&nbsp;to bring&nbsp;clinical trial management in-house, how&nbsp;to&nbsp;modernize&nbsp;trial designs&nbsp;with emerging data and intelligence, overcoming key&nbsp;challenges and advice for other pharma and&nbsp;biotechs&nbsp;looking to go down this path. Learn more in the full episode.&nbsp;</p>","author_name":"Clarivate"}